Imperial College London

Dr Jonathan M Clarke

Faculty of Natural SciencesDepartment of Mathematics

Sir Henry Wellcome Postdoctoral Fellow
 
 
 
//

Contact

 

j.clarke Website

 
 
//

Location

 

St Marys Multiple BuildingsSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Van:2021:10.1007/s00268-021-06099-z,
author = {Van, Den Heede K and Chidambaram, S and Winter, Beatty J and Chander, N and Markar, S and Tolley, NS and Palazzo, FF and Kinross, JK and Di, Marco AN and PanSurg, Collaborative and the PREDICT-Endocrine Collaborative},
doi = {10.1007/s00268-021-06099-z},
journal = {World Journal of Surgery},
pages = {2315--2324},
title = {The PanSurg-PREDICT Study: endocrine surgery during the COVID-19 pandemic},
url = {http://dx.doi.org/10.1007/s00268-021-06099-z},
volume = {45},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - BACKGROUND: In the midst of the COVID-19 pandemic, patients have continued to present with endocrine (surgical) pathology in an environment depleted of resources. This study investigated how the pandemic affected endocrine surgery practice. METHODS: PanSurg-PREDICT is an international, multicentre, prospective, observational cohort study of emergency and elective surgical patients in secondary/tertiary care during the pandemic. PREDICT-Endocrine collected endocrine-specific data alongside demographics, COVID-19 and outcome data from 11-3-2020 to 13-9-2020. RESULTS: A total of 380 endocrine surgery patients (19 centres, 12 countries) were analysed (224 thyroidectomies, 116 parathyroidectomies, 40 adrenalectomies). Ninety-seven percent were elective, and 63% needed surgery within 4 weeks. Eight percent were initially deferred but had surgery during the pandemic; less than 1% percent was deferred for more than 6 months. Decision-making was affected by capacity, COVID-19 status or the pandemic in 17%, 5% and 7% of cases. Indication was cancer/worrying lesion in 61% of thyroidectomies and 73% of adrenalectomies and calcium 2.80 mmol/l or greater in 50% of parathyroidectomies. COVID-19 status was unknown at presentation in 92% and remained unknown before surgery in 30%. Two-thirds were asked to self-isolate before surgery. There was one COVID-19-related ICU admission and no mortalities. Consultant-delivered care occurred in a majority (anaesthetist 96%, primary surgeon 76%). Post-operative vocal cord check was reported in only 14% of neck endocrine operations. Both of these observations are likely to reflect modification of practice due to the pandemic. CONCLUSION: The COVID-19 pandemic has affected endocrine surgical decision-making, case mix and personnel delivering care. Significant variation was seen in COVID-19 risk mitigation measures. COVID-19-related complications were uncommon. This analysis demonstrates the safety of endocrine surgery during this
AU - Van,Den Heede K
AU - Chidambaram,S
AU - Winter,Beatty J
AU - Chander,N
AU - Markar,S
AU - Tolley,NS
AU - Palazzo,FF
AU - Kinross,JK
AU - Di,Marco AN
AU - PanSurg,Collaborative and the PREDICT-Endocrine Collaborative
DO - 10.1007/s00268-021-06099-z
EP - 2324
PY - 2021///
SN - 0364-2313
SP - 2315
TI - The PanSurg-PREDICT Study: endocrine surgery during the COVID-19 pandemic
T2 - World Journal of Surgery
UR - http://dx.doi.org/10.1007/s00268-021-06099-z
UR - https://www.ncbi.nlm.nih.gov/pubmed/33877392
UR - http://hdl.handle.net/10044/1/88624
VL - 45
ER -